Artificial intelligence is becoming a key transformation driver in the pharmaceutical industry.
How can it be effectively integrated into GMP environments while meeting the expectations of Annex 22 and regulatory authorities?
Join this A3P Switzerland event in Lausanne to explore key challenges, gain practical insights, and identify compliant, innovative solutions.